A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2018
At a glance
- Drugs JNJ-5806 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Alios BioPharma
- 25 May 2018 Status changed from recruiting to discontinued as the data received to date did not support continuation of the study.
- 27 Mar 2018 Status changed from not yet recruiting to recruiting.
- 28 Feb 2018 Planned initiation date changed from 4 Feb 2018 to 3 Mar 2018.